Cancer treatment by blocking host-induced IL-1 in combination with radiotherapy
Abstract:
Provided are blocking agents to IL-1α, IL-1β, or IL-1R activity for use in combination with radiotherapy for treating cancer patients in which radiotherapy treatment induces IL-1α, IL-1β or both in their circulation.
Information query
Patent Agency Ranking
0/0